Latest In

Breaking News

The Supreme Court v. Reality: FDA Version

Today the Supreme Court ruled 8-1 that you can’t sue a manufacturer for a defective medical device if the Food and Drug Administration has already approved

Jul 31, 2020
223.2K Shares
3.3M Views
Image has not been found. URL: http://www.washingtonindependent.com/wp-content/uploads/2008/09/law.jpgIllustration by: Matt Mahurin
Today the Supreme Court ruled8-1 that you can’t sue a manufacturer for a defective medical device if the Food and Drug Administration has already approved the device. Legally, perhaps, the decision has its merits. But practically the decision ignores the myriad scandals surrounding the agency that call its core competency into question.
Justice Scalia wrote in his majority opinion that the agency spends 1,200 hours reviewing one device application before granting approval. But it also came to light this week that the agency spent zero hours inspecting a Chinese plant that produced the blood-thinning drug Heparin, distributed by Baxter International Inc. Heparin has been linkedto four deaths and hundreds of accidents. The FDA says it mistakenly went to the wrong plant.
Both the House Committee on Oversight and Government Reform and Energy and Commerce Committee are pushing for an overhaul in the agency. Two weeks ago, heads of both committee’s wrote a letterto the President calling on the FDA’s science advisory board rip up the current budget and start all over again. And this morning Energy and Commerce Subcommittee on Oversight and Investigations Chairman Bart Stupak (D-Mich.) toldthe Wall Street Journal: “[If Americans] knew how little the FDA did to assure the food and drug supply, if the truth ever came out…people would be marching in the street.”
It’s, of course, not the Supreme Court’s fault that the F.D.A. is in crisis. But the high court may end up having a major impact in determining the the agency’s responsibility- they are considering three other cases that involve patients suing for drug and drug labeling.
Today’s ruling suggest that the F.D.A. is the final check on the health care industry. That’s a scary proposition for health care patients.
Paolo Reyna

Paolo Reyna

Reviewer
Paolo Reyna is a writer and storyteller with a wide range of interests. He graduated from New York University with a Bachelor of Arts in Journalism and Media Studies. Paolo enjoys writing about celebrity culture, gaming, visual arts, and events. He has a keen eye for trends in popular culture and an enthusiasm for exploring new ideas. Paolo's writing aims to inform and entertain while providing fresh perspectives on the topics that interest him most. In his free time, he loves to travel, watch films, read books, and socialize with friends.
Latest Articles
Popular Articles